Quantcast
Last updated on April 18, 2014 at 16:16 EDT

Latest Immunity Stories

Molecular Biomarkers Of Vaccine Immunity Identified
2013-12-16 12:33:15

Emory University Testing the efficacy of vaccines in clinical trials takes years, even decades. Yet challenging infections like HIV, malaria and dengue are striking today. To speed up vaccine testing, scientists at the Emory Vaccine Center have established a goal of creating a “vaccine gene chip.” This device could read the activity of all the genes in the genome in white blood cells within a few days of administration of a test vaccine. Reading such “molecular signatures” would...

2013-10-03 04:20:34

TUBINGEN, Germany, Oct. 3, 2013 /PRNewswire/ -- CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza...

2013-08-09 10:17:52

Creating an environment that nurtures the trillions of beneficial microbes in our gut and, at the same time, protects us against invasion by food-borne pathogens is a challenge. A study published on August 8 in PLOS Pathogens reveals the role of a key player in this balancing act. SIGIRR is a protein present at the surface of the cells that line the gut that dampens the innate (non-specific) immune response of these cells to bacteria. The new study, led by Xiaoxia Li (from the Lerner...

2013-07-01 23:21:42

Save 5% on all Titer lab tests from Request A Test in July 2013. Use promo code TITER5 when ordering to save. Brecksville, OH (PRWEB) July 01, 2013 This July, Request A Test, a leading national provider of direct to consumer testing is offering a 5% discount on titer testing. To save, just use promo code TITER5 when placing an order either online or over the phone. Titer testing is a simple way to determine if a person has immunity to a variety of diseases. This time of year finds many...

2013-05-28 10:22:21

A sugar polymer found on the cell surface of multiple pathogens could be key to developing a broad-spectrum vaccine Developing new vaccines to protect against diseases that plague humans is fraught with numerous challenges–one being that microbes tend to vary how they look on the surface to avoid being identified and destroyed by the immune system. However, researchers from Brigham and Women's Hospital (BWH) have discovered a sugar polymer that is common on the cell surface of...

2013-04-18 21:57:35

In a manuscript published today in Immunity, scientists at the Benaroya Research Institute at Virginia Mason (BRI) and the Baylor Institute for Immunology Research (BIIR) report the results of a comparative study of the molecular immune responses to influenza and pneumococcal vaccines. In addition, cutting-edge web technology was used to improve dissemination of data in order to accelerate the pace of scientific discovery. The article features interactive figures that can be customized and...

2013-04-08 12:14:47

Aluminum salts, or alum, have been injected into billions of people as an adjuvant to make vaccines more effective. No one knows, however, how they boost the immune response. In the March 19, 2013, issue of the Proceedings of the National Academy of Sciences researchers at National Jewish Health continue unraveling the mystery of adjuvants with a report that host DNA coats the alum adjuvant and induces two crucial cells to interact twice as long during the initial stimulation of the adaptive...

2013-02-05 12:27:35

NEW YORK, Feb. 5, 2013 /PRNewswire-USNewswire/ -- For over a century, each year has been marked by extraordinary progress in both medicine and biotechnology. Just one hundred years ago, Nicholay Anichkov made the earliest link between cholesterol and atherosclerosis, and Ernest Rutherford and Niels Bohr presented their models--physical and quantum--of the atom. 2013 will not only keep up pace, but will mark an extraordinary period of growth and development in the field of nanodermatology. The...

2012-12-18 08:27:29

PRINCETON, N.J., Dec. 18, 2012 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today the acquisition of a novel drug technology, known as SGX94, representing a unique approach to modulation of the innate immune system. SGX94 is an innate defense regulator (IDR) that regulates the innate immune system to reduce inflammation, eliminate infection and enhance tissue healing by binding to the pivotal regulatory...

2012-11-13 12:45:13

Sexually-transmitted diseases (STDs) enter the body through the mucosal epithelial cells and the ability to direct pathogen-clearing T-cells to points of infection may be the critical element in developing successful vaccines against these infections. In a study published in the Journal of Clinical Investigation, researchers led by John Schiller at the National Cancer Institute investigated the immune response to intravaginal immunization in mice infected with a form of the HPV virus carrying...